's Avatar

@bethcd.bsky.social

Postdoc in infectious disease epidemiology and modelling at University of Cambridge. Interested in arboviruses, vaccines, and immunity. Previously at Imperial College London.

40 Followers  |  84 Following  |  7 Posts  |  Joined: 02.04.2025  |  1.7193

Latest posts by bethcd.bsky.social on Bluesky

Preview
Forming the LGBTQIA+ International Support Group - Imperial Medicine Blog LGBTQIA+ travellers can face unique challenges when travelling abroad. That’s why, researchers from the School of Public Health set up the LGBTQIA+ International Support Group.

Curious about our work?
You can read more about our experiences setting up the group: blogs.imperial.ac.uk/imperial-med... blogs.imperial.ac.uk/imperial-med...

05.07.2025 10:44 — 👍 0    🔁 0    💬 0    📌 0

Proud of our work supporting LGBTQIA+ scientists conducting international research! 🌍🏳️‍🌈 Whether you're part of the community or an ally, explore the resources and support we've put together here 👉 www.imperial.ac.uk/school-publi...

05.07.2025 10:43 — 👍 1    🔁 0    💬 1    📌 0
Preview
Forming the LGBTQIA+ International Support Group - Imperial Medicine Blog LGBTQIA+ travellers can face unique challenges when travelling abroad. That’s why, researchers from the School of Public Health set up the LGBTQIA+ International Support Group.

Curious about our work?
We shared our experiences in these blog posts: blogs.imperial.ac.uk/imperial-med... blogs.imperial.ac.uk/imperial-med...

05.07.2025 10:41 — 👍 0    🔁 0    💬 0    📌 0
Post image Post image

Ipswich looking glorious in the sun. Brilliant 48h with the @pducambridge.bsky.social solving the pressing questions in infectious diseases, competing in penalty shoot outs and cooking up a storm #PDURetreat

04.07.2025 08:36 — 👍 6    🔁 5    💬 0    📌 1

Our work helped inform WHO policy on dengue vaccines—supporting the strategic use of Qdenga where it can do the most good. Huge thanks to my PhD supervisors Ilaria Dorigatti & Neil Ferguson for the opportunity and their support on this project!

25.06.2025 10:38 — 👍 0    🔁 0    💬 0    📌 0

Key findings:
1. Protection varies by serostatus & serotype
2. Cannot rule out an enhanced disease risk for seronegatives infected with serotypes 3 and 4, esp in children <6 years
3. Targeted Qdenga rollout (>6 yrs in high transmission settings) could still reduce hospitalisation burden by up to 20%

25.06.2025 10:38 — 👍 0    🔁 0    💬 1    📌 0

We built a Bayesian model linking antibody titres to protection-by—serotype, age & serostatus—and embedded it in a transmission model to evaluate real-world impact across settings.

25.06.2025 10:38 — 👍 1    🔁 0    💬 1    📌 0

Our new paper is out in @natmed.nature.com! We modelled the efficacy & public-health impact of the new Takeda #dengue vaccine (Qdenga), combining trial data with transmission models to guide optimal #vaccine use: rdcu.be/etk3h. 🧵👇

25.06.2025 10:38 — 👍 2    🔁 0    💬 1    📌 0

@bethcd is following 20 prominent accounts